Welcome to LookChem.com Sign In|Join Free
  • or
1-Naphthalenesulfonyl chloride, 4-(benzoylamino)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

723308-60-9

Post Buying Request

723308-60-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

723308-60-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 723308-60-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,3,3,0 and 8 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 723308-60:
(8*7)+(7*2)+(6*3)+(5*3)+(4*0)+(3*8)+(2*6)+(1*0)=139
139 % 10 = 9
So 723308-60-9 is a valid CAS Registry Number.

723308-60-9Upstream product

723308-60-9Relevant academic research and scientific papers

Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8

Jenkins, Tracy J.,Guan, Bing,Dai, Mingshi,Li, Gang,Lightburn, Thomas E.,Huang, Shan,Freeze, B. Scott,Burdi, Douglas F.,Jacutin-Porte, Swanee,Bennett, Robert,Chen, Weirong,Minor, Charles,Ghosh, Shomir,Blackburn, Christopher,Gigstad, Kenneth M.,Jones, Matthew,Kolbeck, Roland,Yin, Wei,Smith, Sean,Cardillo, Daniel,Ocain, Timothy D.,Harriman, Geraldine C.

, p. 566 - 584 (2008/04/18)

The design, synthesis, and structure-activity relationship development of naphthalene-derived human CCR8 antagonists is described. In vitro binding assay results of these investigations are reported, critical interactions of the antagonists with CCR8 are

CCR8 INHIBITORS

-

Page 38, (2008/06/13)

Disclosed are CCR8 inhibitors represented by Structural Formulas (I). The variables in Structural Formula (I) are described herein. Also disclosed are methods of treating a subject with a CCR8 mediated condition, especially asthma, by administering one of the disclosed CCR8 inhibitors to the subject.

CCR8 INHIBITORS

-

Page 33, (2008/06/13)

Disclosed is an inhibitor of CCR8 that is represented by Structural Formula (I). Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier or diluent and a CCR8 inhibitor represented by Structural Formula (I). Also disclosed is a method of treating inflammatory disorders in a subject by administering a CCR8 inhibitor to the subject.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 723308-60-9